LepiDyne

Seoul, South Korea Founded: 2019 • Age: 7 yrs
Developer of liquid biopsy test kits for cancer detection

About LepiDyne

LepiDyne is a Healthcare company based in Seoul (South Korea) founded in 2019. Developer of liquid biopsy test kits for cancer detection. Its chief executive, as recorded, is Young Joon Kim. LepiDyne offers products and services including MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity in India is (μ£Ό)λ ˆν”Όλ‹€μΈ (U99999MH1977PLC010754).

Company details

LepiDyne was founded in 2019 in Seoul, South Korea, where tumor-specific DNA methylation markers in blood are discovered, developed, and clinically validated for cancer detection. Operations center on liquid biopsy technologies within the biotechnology sector. Key products, including MethyLiverDx, MethyLiverPro, and MethyLiverMT, are offered for liver cancer diagnostics. Leadership is provided by CEO Young Joon Kim, with activities based in South Korea.

  • Headquarters Seoul, South Korea
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website lepidyne.com
  • Legal Name (주)레피다인
  • Date of Incorporation 10 Aug, 1977
  • Jurisdiction Maharashtra, India
Operational Areas

Products & Services of LepiDyne

LepiDyne offers a comprehensive portfolio of products and services, including MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag.

MethyLiverDx
Diagnostic Kit

Kit for early blood-based diagnosis of liver cancer

MethyLiverPro
Diagnostic Kit

Kit for predicting liver cancer treatment outcomes

MethyLiverMT
Diagnostic Kit

Kit for monitoring liver cancer treatment progress

LepiMag
Extraction Kit

Kit for extracting cell-free DNA from blood samples

People of LepiDyne

1 people are tracked at LepiDyne (1 in leadership).

NameRoleGroup
Young Joon Kim
CEOLeadership
Premium access

Complete people profiles for LepiDyne

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of LepiDyne

The website of LepiDyne (lepidyne.com) receives about 1.8K visits a month.

  • Monthly visits
    1.8K

    ▲ 135.2% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lepidyne

Premium access

Complete news archive for LepiDyne

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LepiDyne

LepiDyne was founded in 2019.

LepiDyne is headquartered in Seoul, South Korea.

Young Joon Kim is the CEO of LepiDyne, as recorded in our data.

LepiDyne was founded in 2019 in Seoul, South Korea, where tumor-specific DNA methylation markers in blood are discovered, developed, and clinically validated for cancer detection. Operations center on liquid biopsy technologies within the biotechnology sector. Key products, including MethyLiverDx, MethyLiverPro, and MethyLiverMT, are offered for liver cancer diagnostics. Leadership is provided by CEO Young Joon Kim, with activities based in South Korea.

LepiDyne offers MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag.

LepiDyne operates through ,.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available